Page last updated: 2024-09-05

isospaglumic acid and Cognitive Dysfunction

isospaglumic acid has been researched along with Cognitive Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alt, J; Barker, PB; Brandt, J; Calabresi, PA; Crainiceau, CM; Grishkan, I; Kaplin, AI; Pletnikov, MV; Pomper, MG; Rahn, KA; Rais, R; Rojas, C; Slusher, BS; Stathis, M; Watkins, CC1

Other Studies

1 other study(ies) available for isospaglumic acid and Cognitive Dysfunction

ArticleYear
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Dec-04, Volume: 109, Issue:49

    Topics: Adult; Analysis of Variance; Animals; Cognitive Dysfunction; Dipeptides; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Glutamate Carboxypeptidase II; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuropsychological Tests; Organophosphorus Compounds

2012